Pennsylvania has joined 22 other states in challenging new Trump administration conditions on federal family-planning grants that target transgender-inclusive programs and diversity, equity and inclusion practices.
The lawsuit, filed August 27, challenges requirements attached to the next round of Title X grants. Pennsylvania received $12.73 million through the federal program in fiscal year 2026.
Title X supports contraception, STI testing and treatment, cancer screenings and other reproductive and preventive health services, particularly for low-income and uninsured patients.
Pittsburgh-based Adagio Health is the region’s current Title X grantee, overseeing a network spanning 23 counties. Its services include STI and HIV testing, contraception, preventive care and HIV prevention medications PrEP and PEP.
Under the new federal funding priorities, applicants are expected to demonstrate alignment with administration policies that include “ending support for gender ideology” and eliminating DEI practices. Pennsylvania argues the administration is improperly injecting political requirements into a public health program created by Congress.
For queer and trans patients, the unresolved question is whether providers like Adagio could remain competitive for federal funding without changing transgender-inclusive practices.